← Back to Search

Mineral Supplement

Magnesium Supplements for High Blood Pressure

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Total Mg intake from supplements of no more than 100 mg/day
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will test whether magnesium glycinate lowers blood pressure.

Who is the study for?
This trial is for adults with high blood pressure (systolic 120-149 mmHg or diastolic 80-94 mmHg) who are willing to keep their diet and supplement intake the same during the study. They must have a BMI under 35, not take more than 100 mg/day of magnesium supplements, and cannot be planning to move out of Boston within a year.Check my eligibility
What is being tested?
The trial is testing if taking magnesium glycinate (480 mg/day) for three months can lower blood pressure. Participants will either receive this supplement or a placebo without knowing which one they're getting.See study design
What are the potential side effects?
While not specified here, common side effects from magnesium supplements may include stomach upset, diarrhea, nausea, and vomiting. However, individual reactions can vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I take 100 mg or less of magnesium supplements daily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in 24-hour ambulatory blood pressure from baseline to 12 weeks
Change in seated blood pressure from baseline to 12 weeks
Secondary outcome measures
Change in aldosterone level from baseline to 12 weeks
Change in angiotensin II level from baseline to 12 weeks
Change in creatinine level from baseline to 12 weeks
+5 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: magnesiumActive Control1 Intervention
magnesium glycinate supplement, 480 mg/day
Group II: placeboPlacebo Group1 Intervention
placebo supplement

Find a Location

Who is running the clinical trial?

Pure EncapsulationsIndustry Sponsor
1 Previous Clinical Trials
120 Total Patients Enrolled
Brigham and Women's HospitalLead Sponsor
1,604 Previous Clinical Trials
11,466,878 Total Patients Enrolled

Media Library

Magnesium Glycinate Supplement (Mineral Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03688503 — N/A
High Blood Pressure Research Study Groups: magnesium, placebo
High Blood Pressure Clinical Trial 2023: Magnesium Glycinate Supplement Highlights & Side Effects. Trial Name: NCT03688503 — N/A
Magnesium Glycinate Supplement (Mineral Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03688503 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment accepting individuals aged forty and over?

"This study is searching for participants of a certain age range; they must be over 40 years old and under 69."

Answered by AI

Is enrollment for this trial presently available?

"Data on clinicaltrials.gov states that this trial is not presently searching for patients; its initial post date being February 15th, 2019 and its most recent update occurring August 3rd 2022. Even though it's currently inactive, 104 other studies are looking for participants at the moment."

Answered by AI

Is it feasible for me to take part in this medical experiment?

"To qualify for the trial, eligible participants should have their blood pressure in a healthy range and be between 40-69 years old. 59 patients are presently being sought after."

Answered by AI
~10 spots leftby Mar 2025